 |
Previous Article | Next Article 
The Journal of Neuroscience, December 1, 1998, 18(23):10150-10156
Long-Term Antidepressant Treatments Result in a Tonic Activation
of Forebrain 5-HT1A Receptors
Nasser
Haddjeri,
Pierre
Blier, and
Claude
de Montigny
Neurobiological Psychiatry Unit, McGill University, Montréal,
Québec, Canada H3A 1A1
We report here the first direct functional evidence of an increase
in the tonic activation of postsynaptic 5-HT1A receptors by
antidepressant treatments. Because 5-HT1A receptor
activation hyperpolarizes and inhibits CA3 pyramidal
neurons in the dorsal hippocampus, we determined, using in
vivo extracellular recording, whether the selective
5-HT1A receptor antagonist WAY 100635 could disinhibit
these neurons. Unexpectedly, no disinhibition could be detected in
controls. However, after long-term treatment with the tricyclic
antidepressant imipramine, the selective 5-HT reuptake inhibitor
paroxetine, the reversible monoamine oxidase-A inhibitor befloxatone, the 2-adrenergic antagonist mirtazapine, or
the 5-HT1A receptor agonist gepirone or multiple
electroconvulsive shock (ECS) administration, WAY 100635 markedly
increased (60-200%) the firing activity of CA3 pyramidal
neurons. Such a disinhibition was absent in rats treated with the
nonantidepressant drug chlorpromazine, in rats receiving only one ECS,
or in rats receiving multiple ECSs in combination with an
intrahippocampal pertussis toxin treatment to inactivate
Gi/o-coupled 5-HT1A receptors. These data
indicate that such antidepressant treatments, acting on entirely
different primary targets, might alleviate depression by enhancing the
tonic activation of forebrain postsynaptic 5-HT1A receptors.
Key words:
antidepressants; serotonin (5-HT); 5-HT1A
receptors; WAY 100635; disinhibition; dorsal hippocampus
Copyright © 1998 Society for Neuroscience 0270-6474/98/182310150-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
K. Kobayashi, Y. Ikeda, E. Haneda, and H. Suzuki
Chronic Fluoxetine Bidirectionally Modulates Potentiating Effects of Serotonin on the Hippocampal Mossy Fiber Synaptic Transmission
J. Neurosci.,
June 11, 2008;
28(24):
6272 - 6280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Bermack and G. Debonnel
Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors
J Psychopharmacol,
January 1, 2007;
21(1):
85 - 92.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Goldapple, Z. Segal, C. Garson, M. Lau, P. Bieling, S. Kennedy, and H. Mayberg
Modulation of Cortical-Limbic Pathways in Major Depression: Treatment-Specific Effects of Cognitive Behavior Therapy
Arch Gen Psychiatry,
January 1, 2004;
61(1):
34 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Mayberg, J. A. Silva, S. K. Brannan, J. L. Tekell, R. K. Mahurin, S. McGinnis, and P. A. Jerabek
The Functional Neuroanatomy of the Placebo Effect
Am J Psychiatry,
May 1, 2002;
159(5):
728 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Duman, J. Malberg, and S. Nakagawa
Regulation of Adult Neurogenesis by Psychotropic Drugs and Stress
J. Pharmacol. Exp. Ther.,
November 1, 2001;
299(2):
401 - 407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. l. Cour, C. Boni, N. Hanoun, K.-P. Lesch, M. Hamon, and L. Lanfumey
Functional Consequences of 5-HT Transporter Gene Disruption on 5-HT1A Receptor-Mediated Regulation of Dorsal Raphe and Hippocampal Cell Activity
J. Neurosci.,
March 15, 2001;
21(6):
2178 - 2185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Malberg, A. J. Eisch, E. J. Nestler, and R. S. Duman
Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
J. Neurosci.,
December 15, 2000;
20(24):
9104 - 9110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Lyons, L. A. Mamounas, G. A. Ricaurte, V. Coppola, S. W. Reid, S. H. Bora, C. Wihler, V. E. Koliatsos, and L. Tessarollo
Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities
PNAS,
December 21, 1999;
96(26):
15239 - 15244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pineyro and P. Blier
Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Pharmacol. Rev.,
September 1, 1999;
51(3):
533 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|